CN104055887A - External application vulnerary - Google Patents
External application vulnerary Download PDFInfo
- Publication number
- CN104055887A CN104055887A CN201410338772.6A CN201410338772A CN104055887A CN 104055887 A CN104055887 A CN 104055887A CN 201410338772 A CN201410338772 A CN 201410338772A CN 104055887 A CN104055887 A CN 104055887A
- Authority
- CN
- China
- Prior art keywords
- medicine
- vulnerary
- external application
- category
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to a vulnerary and in particular relates to an external application vulnerary used for traumatic injury or broken bone splicing. According to the external application vulnerary, traditional Chinese medicines with effects of relieving swelling and pain, promoting blood circulation to remove blood stasis and dredging collaterals and splicing bones are taken as monarch drugs, and acceptable medicines in prescriptions of traditional Chinese medicine are taken as ministerial drugs; the ministerial drugs comprise type A, type B and type C of drugs; the type A drugs have the effects of splicing the bones, the type B drugs have the effects of promoting blood circulation to remove blood stasis, and the type C drugs have the effects of dredging collaterals and relieving pain or cooling blood and relieving pain. The various traditional Chinese medicines are common traditional Chinese medicines and are wide in source and low in price, and standard production is easily realized. The external application vulnerary has a good trauma treatment effect.
Description
Technical field
The present invention relates to a kind of vulnerary, relate in particular to a kind of external application vulnerary for traumatic injury or knochenbruch continued access.
Background technology
Traumatic injury is common slight illness, and there is the medicine of set a broken bone in Chinese medicine field more, as Cortex Phellodendri, Radix Angelicae Sinensis, interrupted, the Cortex Eucommiae, Olibanum, Myrrha etc.And having folk prescription among the people more, the folk prescription of different regions is different; Some folk prescriptions among the people have special effect in the time for the treatment of traumatic injury.Right this class folk prescription is not by the public is known, and majority is that the form passing on from one to another with ancestors is grasped in a few peoples' hands.
Prior art generally adopts Moschus Analgesic Unguentum or Os Tigris Emplastrum Moschus external application for curing, but this medicine uses relatively limitation, general only for the slight closed injury of degree, as sprains; For more serious sick and wounded, weak effect, take effect slow; Especially for the damage of some openings, damage and cause knochenbruch as serious traumatic injury, several inefficacies.Prior art takes Gypsum Fibrosum to fix after solving when open injury, normally correcting position, and rehabilitation is mainly the recovery capability that relies on patient self.
Application number is 201010148013.5 Chinese invention patent, discloses a kind of orthopedics department application compress, is made up of the crude drug of following weight portion: 4～10 parts of Radix Et Rhizoma Rhei, 3～7 parts of Cortex Phellodendris, 4～8 parts of Radix Scutellariaes, 2～8 parts of the Radixs Angelicae Dahuricae, 4～8 parts of Radix Sanguisorbaes, 5～7 parts of Radix Paeoniae Rubra, 4～8 parts of Cortex Moutans, 4～8 parts of Fructus Gardeniaes, 3～9 parts, Flos Carthami, 3～7 parts of Herba Lycopi, 4～8 parts of Radix Angelicae Sinensis, 2～6 parts of the Radixs Linderae, 2～6 parts of Rhizoma Cyperis, 3～9 parts of Rhizoma Corydalis, 3～9 parts, Rhizoma Curcumae Longae, 2～6 parts of Radix Dipsacis, 2～6 parts of Rhizoma Et Radix Notopterygiis.Above-mentioned raw materials medicine makes that traumatology external application is loose, orthopedics department external application ointment or orthopedics department external application hot compress powder, adopt different dosage forms to treat according to the different sequential such as the fracture patient state of an illness residing early stage, mid-term, later stage, three kinds of medicine uses capable of being combined, energy fast treating fracture of the present invention, effective percentage 100%, dispenser is flexible, targeting is strong, can effectively reach fracture site, bring into play better the due effect of medicine, greatly reduce the generation of adverse effect, prevent the waste of drug resource, shortened the time of union of fracture.
Summary of the invention
The present invention will solve bone injury and recover slow problem, and a kind of external application vulnerary that can fast and effeciently treat all kinds of damages is provided in addition.
The technical scheme that the present invention addresses the above problem is as follows:
External application vulnerary, taking the Chinese medicine with reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, dredging collateral synthetism effect as monarch drug, taking acceptable medicine on science of prescription as ministerial drug; Described ministerial drug comprises category-A, category-B and C class, and category-A medical instrument has the effect of synthetism symplectic bone, category-B medical instrument to have function of promoting blood circulation to disperse blood clots, C class medical instrument to have removing obstruction in the collateral to relieve pain or cooling blood and relieving pain effect.
Monarch drug: the main symptom to prescription or main disease play the medicine of primary treatment effect in prescription.It has embodied the main direction of prescription, in its efficacy of a drug residence side first of, be indispensable medicine in prescription.
Ministerial drug: be the medicine that auxiliary monarch drug is strengthened the main disease for the treatment of and main symptom.
Adjuvant drug: be supplementary drug, be used for the treatment of the medicine of less important accompanied symptoms.
Make medicine: be guiding drug, in the side of drawing all medicines through sick medicine.
As technique scheme preferably, described monarch drug is yangtao actinidia root bark; Described category-A medicine is selected from one or more in Zaocys rattan, Cortex Albiziae and Cortex cercis chinensis; Described category-B medicine is selected from one or more in Radix Salviae Miltiorrhizae, Radix Rubiae, herba lycopi; Described C class medicine is selected from one or more in phellodendron bark, Folium Hibisci Mutabilis and Radix Aristolochiae.
As technique scheme preferably, also comprise adjuvant drug, described adjuvant drug is Borax.
As technique scheme preferably, also comprise and make medicine, described in to make medicine be the medicine that pungent perfume (or spice) is walked to alter.
As technique scheme preferably, described in to make medicine be Camphora.
As technique scheme preferably, described each medicine mass parts is as follows:
Monarch drug 5～10
Ministerial drug category-A 2～5
Ministerial drug category-B 2～5
Ministerial drug C class 2～5.
As technique scheme preferably, also comprise that mass parts is 0.1～0.5 adjuvant drug.
As technique scheme preferably, also comprise that mass parts is 0.1～0.3 the medicine that makes.
As technique scheme preferably, the medicine that comprises following mass parts:
Yangtao actinidia root bark 5～8
Zaocys rattan 0.5～2.0
Cortex Albiziae 0.5～2.0
Cortex cercis chinensis 0.5～2.0
Radix Salviae Miltiorrhizae 0.5～2.0
Radix Rubiae 0.5～2.0
Herba lycopi 0.5～2.0
Phellodendron bark 0.5～2.0
Folium Hibisci Mutabilis 0.8～2.5
Radix Aristolochiae 0.8～2.5
Borax 0.1～0.4
Camphora 0.05～0.2.
As technique scheme preferably, the medicine that comprises following mass parts:
Yangtao actinidia root bark 5～6
Zaocys rattan 0.8～1.2
Cortex Albiziae 0.8～1.2
Cortex cercis chinensis 0.8～1.2
Radix Salviae Miltiorrhizae 0.8～1.2
Radix Rubiae 0.8～1.2
Herba lycopi 0.8～1.2
Phellodendron bark 0.8～1.2
Folium Hibisci Mutabilis 1.3～1.7
Radix Aristolochiae 1.3～1.7
Borax 0.15～0.25
Camphora 0.08～0.12.
Wu--, man 59 years old Huzhou City of Zhejiang Province Zhong Zhang people from village, Anji County Bao Fu town, wound causes the left gonalgia a few days, is left meniscus injury (breaking) through many hospital diagnosis, with interlocking symptom, suggestion operative treatment, I refuse; Through application the present invention two months, movable as usual, recovery from illness.
Qiu--, 54 years old Huzhou City of Zhejiang Province of female hair people from mountain village, Anji County chapter villages and small towns, companion is comminuted for compression fracture of lumbar vertebra, through application the present invention three months, heals, movable as usual.
Yellow--, man 52 years old Huzhou City of Zhejiang Province Anji County Di Pu town people from economic development zone, wound causes left lower extremity fracture of tibia, manual reduction, after fixing, external application the present invention, 40 days bone wound healings, can walk.
--, 53 years old Huzhou City of Zhejiang Province of female Anji County Bao Fu town worker of commune hospital, the brick right dorsal portion of wounding, swelling, cyanosis of the skin, hurt like hell, through this external application the present invention, half an hour is pain relieving immediately, lump Periostracum Cicadae after 1 day.
Pan--, 74 years old right fracture of femoral neck of female, suggestion operative treatment, this members refusal, through external application the present invention, can descend and walk for two months, takes care of oneself.
Lu--, man 63 years old Huzhou City of Zhejiang Province Bao Fu people from village, Anji County Bao Fu town, mails the present invention to U.S. relative place, wins the favorable judgment.
Yu--, man 55 years old Huzhou City of Zhejiang Province Zhang Cun people from village, Anji County chapter villages and small towns, repeatedly mails the present invention to Rwanda, obtains family numbers of patients favorable comment.
Bears--, 46 years old Huzhou City of Zhejiang Province Anji County filial piety Fengzhen of female bridge people from village that learn something in history, traffic accident causes fl fracture, underwent operative treatment, Plate break nonunion after 10 months, unbearably, through this external application the present invention, callus is local to be formed in local swelling, and swelling is disappeared.
Miao--, the precious kind bridge people native to a place in 85 years old Hangzhou, Zhejiang province of female city, wound causes right fracture of capitulum radii, suggestion operative treatment, I refuse, through manual reduction, external application the present invention, callus healing after three months, functional activity is normal.
In sum, the present invention has following beneficial effect:
1, all kinds of Chinese medicine of the present invention is common Chinese medicine, and source is wide, and price is low, easily realizes standardized production;
2, the present invention has good wound and controls effect.
Detailed description of the invention
This detailed description of the invention is only explanation of the invention, is not limitation of the present invention.Any amendment that those skilled in the art have done after having read description of the present invention, as long as in the protection domain of claim, all will be subject to the protection of Patent Law.
Embodiment mono-
External application vulnerary, the medicine that comprises following mass parts:
Yangtao actinidia root bark 5
Zaocys rattan 0.5
Cortex Albiziae 0.5
Cortex cercis chinensis 0.5
Radix Salviae Miltiorrhizae 0.5
Radix Rubiae 0.5
Herba lycopi 0.5
Phellodendron bark 0.5
Folium Hibisci Mutabilis 0.8
Radix Aristolochiae 0.8
Borax 0.1
Camphora 0.05.
Embodiment bis-
External application vulnerary, the medicine that comprises following mass parts:
Yangtao actinidia root bark 6
Zaocys rattan 1. 0
Cortex Albiziae 1.0
Cortex cercis chinensis 1.0
Radix Salviae Miltiorrhizae 1.0
Radix Rubiae 1.0
Herba lycopi 1.0
Phellodendron bark 1.0
Folium Hibisci Mutabilis 1.5
Radix Aristolochiae 1.5
Borax 0.2
Camphora 0.1.
Embodiment tri-
External application vulnerary, the medicine that comprises following mass parts:
Yangtao actinidia root bark 5
Zaocys rattan 1.0
Cortex Albiziae 1.0
Cortex cercis chinensis 1.0
Radix Salviae Miltiorrhizae 1.0
Radix Rubiae 1.0
Herba lycopi 1.0
Phellodendron bark 1.0
Folium Hibisci Mutabilis 1.5
Radix Aristolochiae 1.5
Borax 0.2
Camphora 0.1.
Embodiment tetra-
External application vulnerary, the medicine that comprises following mass parts:
Yangtao actinidia root bark 7
Zaocys rattan 1.5
Cortex Albiziae 1.5
Cortex cercis chinensis 1.5
Radix Salviae Miltiorrhizae 1.5
Radix Rubiae 1.5
Herba lycopi 1.5
Phellodendron bark 1.5
Folium Hibisci Mutabilis 1.7
Radix Aristolochiae 1.7
Borax 0.25
Camphora 0.12.
Embodiment five
External application vulnerary, the medicine that comprises following mass parts:
Yangtao actinidia root bark 8
Zaocys rattan 2.0
Cortex Albiziae 2.0
Cortex cercis chinensis 2.0
Radix Salviae Miltiorrhizae 2.0
Radix Rubiae 2.0
Herba lycopi 2.0
Phellodendron bark 2.0
Folium Hibisci Mutabilis 2.5
Radix Aristolochiae 2.5
Borax 0.4
Camphora 0.2.
Claims (10)
1. external application vulnerary, is characterized in that: taking the Chinese medicine with reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, dredging collateral synthetism effect as monarch drug, taking acceptable medicine on science of prescription as ministerial drug; Described ministerial drug comprises category-A, category-B and C class, and category-A medical instrument has the effect of synthetism symplectic bone, category-B medical instrument to have function of promoting blood circulation to disperse blood clots, C class medical instrument to have removing obstruction in the collateral to relieve pain or cooling blood and relieving pain effect.
2. external application vulnerary according to claim 1, is characterized in that: described monarch drug is yangtao actinidia root bark; Described category-A medicine is selected from one or more in Zaocys rattan, Cortex Albiziae and Cortex cercis chinensis; Described category-B medicine is selected from one or more in Radix Salviae Miltiorrhizae, Radix Rubiae, herba lycopi; Described C class medicine is selected from one or more in phellodendron bark, Folium Hibisci Mutabilis, Radix Aristolochiae.
3. external application vulnerary according to claim 1, is characterized in that: also comprise adjuvant drug, described adjuvant drug is Borax.
4. external application vulnerary according to claim 1, is characterized in that: also comprise and make medicine, described in to make medicine be the medicine that pungent perfume (or spice) is walked to alter.
5. external application vulnerary according to claim 4, is characterized in that: described in to make medicine be Camphora.
6. external application vulnerary according to claim 2, is characterized in that: described each medicine mass parts is as follows:
Monarch drug 5～10
Ministerial drug category-A 2～5
Ministerial drug category-B 2～5
Ministerial drug C class 2～5.
7. external application vulnerary according to claim 6, is characterized in that: also comprise that mass parts is 0.1～0.5 adjuvant drug.
8. external application vulnerary according to claim 6, is characterized in that: also comprise that mass parts is 0.1～0.3 the medicine that makes.
9. external application vulnerary according to claim 1, is characterized in that: the medicine that comprises following mass parts:
Yangtao actinidia root bark 5～8
Zaocys rattan 0.5～2.0
Cortex Albiziae 0.5～2.0
Cortex cercis chinensis 0.5～2.0
Radix Salviae Miltiorrhizae 0.5～2.0
Radix Rubiae 0.5～2.0
Herba lycopi 0.5～2.0
Phellodendron bark 0.5～2.0
Folium Hibisci Mutabilis 0.8～2.5
Radix Aristolochiae 0.8～2.5
Borax 0.1～0.4
Camphora 0.05～0.2.
10. external application vulnerary according to claim 9, is characterized in that: the medicine that comprises following mass parts:
Yangtao actinidia root bark 5～6
Zaocys rattan 0.8～1.2
Cortex Albiziae 0.8～1.2
Cortex cercis chinensis 0.8～1.2
Radix Salviae Miltiorrhizae 0.8～1.2
Radix Rubiae 0.8～1.2
Herba lycopi 0.8～1.2
Phellodendron bark 0.8～1.2
Folium Hibisci Mutabilis 1.3～1.7
Radix Aristolochiae 1.3～1.7
Borax 0.15～0.25
Camphora 0.08～0.12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410338772.6A CN104055887B (en) | 2014-07-17 | 2014-07-17 | External application vulnerary |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410338772.6A CN104055887B (en) | 2014-07-17 | 2014-07-17 | External application vulnerary |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104055887A true CN104055887A (en) | 2014-09-24 |
| CN104055887B CN104055887B (en) | 2016-05-11 |
Family
ID=51544006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410338772.6A Active CN104055887B (en) | 2014-07-17 | 2014-07-17 | External application vulnerary |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104055887B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958696A (en) * | 2015-06-26 | 2015-10-07 | 安良云 | Traditional Chinese medicine composition for treating traumatic injuries |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049430A (en) * | 2007-05-11 | 2007-10-10 | 宋振江 | External ointment for treating bone fracture |
| CN103623350A (en) * | 2013-12-05 | 2014-03-12 | 青岛中科菲力工程技术研发有限公司 | Traditional Chinese medicine plaster with effect of boosting fracture healing |
-
2014
- 2014-07-17 CN CN201410338772.6A patent/CN104055887B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049430A (en) * | 2007-05-11 | 2007-10-10 | 宋振江 | External ointment for treating bone fracture |
| CN103623350A (en) * | 2013-12-05 | 2014-03-12 | 青岛中科菲力工程技术研发有限公司 | Traditional Chinese medicine plaster with effect of boosting fracture healing |
Non-Patent Citations (2)
| Title |
|---|
| 周文扬: "中药外敷疗法治疗跌打损伤", <<中医外治杂志>>, vol. 8, no. 6, 31 December 1999 (1999-12-31), pages 42 * |
| 张强等: "中药藤梨根研究概况", <<中国中医药信息杂志>>, vol. 15, no. 11, 30 November 2008 (2008-11-30), pages 101 - 103 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958696A (en) * | 2015-06-26 | 2015-10-07 | 安良云 | Traditional Chinese medicine composition for treating traumatic injuries |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104055887B (en) | 2016-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327380B (en) | Chinese medicinal composition for treating knee osteoarthritis | |
| CN105727241A (en) | Plaster | |
| CN100528194C (en) | Medicine for treating femoral head necrosis | |
| CN103479837A (en) | External medicine for curing hyperosteogeny and preparation method thereof | |
| CN104324100A (en) | Traditional Chinese medicine ointment for treating ganglion and preparation method thereof | |
| WO2021042275A1 (en) | Traditional chinese medicine composition for treating osteoarthritis | |
| CN103099863B (en) | Traditional Chinese medicine preparation externally used for treating meniscus injury of knee joint | |
| CN103099869B (en) | Traditional Chinese medicine wine for treating blood obstructing lubar intervertebral disc protrusion | |
| CN104055887B (en) | External application vulnerary | |
| CN104027394A (en) | Traditional Chinese medicine preparation for treating fracture and traumatic injury | |
| CN101279080B (en) | Medicament composition for curing cervical vertebra disease, lumbar disease and traumatic injury and preparation method | |
| CN103585294B (en) | A kind of for plaster treating hyperosteogeny and preparation method thereof | |
| CN102579743A (en) | Externally applied ointment mainly for treating bone fracture and degenerative osteopathy and preparation method thereof | |
| CN100394925C (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN104383424B (en) | Promote the pharmaceutical composition of union | |
| CN109966451A (en) | A kind of Chinese medicine composition of bone-setting and pain-relieving | |
| CN103127344B (en) | The Chinese medicine preparation for the treatment of nonunion, the healing of fracture slowness and preparation method | |
| CN103386050B (en) | Chinese patent drug pill used for treating rheumatic ostealgia, cervical spondylosis and lumbar spondylosis | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN104491667B (en) | A method of preparing the pharmaceutical composition for union | |
| CN106361840A (en) | Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof | |
| CN106581276B (en) | Dieda plaster for curing traumatic injury | |
| CN105560427A (en) | Transdermal gate-freeing powder | |
| CN104547915A (en) | Traditional Chinese medicine composition for treating traumatic injury and medicinal liquor | |
| CN105168753A (en) | Traditional Chinese medicine ointment for treating neck-shoulder pain or lumbocrural pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |